Basing Eligibility for Lung Cancer Screening on Individualized Risk Calculators Should Save More Lives, but Life Expectancy Matters

Affiliations

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD.

Editorial

Hormuzd A Katki et al. J Natl Cancer Inst. 2020.

. 2020 May 1;112(5):429-430.

doi: 10.1093/jnci/djz165.

¹ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD.

No abstract available

Comment on

A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies.
Ten Haaf K, Bastani M, Cao P, Jeon J, Toumazis I, Han SS, Plevritis SK, Blom EF, Kong CY, Tammemägi MC, Feuer EJ, Meza R, de Koning HJ. Ten Haaf K, et al. J Natl Cancer Inst. 2020 May 1;112(5):466-479. doi: 10.1093/jnci/djz164. J Natl Cancer Inst. 2020. PMID: 31566216 Free PMC article.

1. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. - PMC - PubMed
1. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(5):311–320. - PMC - PubMed
1. Moyer VA; U.S. Preventive Services Task Force . Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(5):330–338.. - PubMed
1. Bach PB, Gould MK.. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012;157(8):571–573. - PubMed
1. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013;369(3):245–254. - PMC - PubMed